Phase 1B Study Combining Ibrutinib with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-Chop) in Patients with Cd20-Positive B-Cell Non-Hodgkin Lymphoma (NHL)

Younes, A; ...; Todorovic, M; ...; (broj, koautora 16)

Rezultati

eNauka > Results > Phase 1B Study Combining Ibrutinib with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-Chop) in Patients with Cd20-Positive B-Cell Non-Hodgkin Lymphoma (NHL)

Title:	Phase 1B Study Combining Ibrutinib with Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-Chop) in Patients with Cd20-Positive B-Cell Non-Hodgkin Lymphoma (NHL)
Authors:	Younes, A; ...; Todorovic, M; ...; (broj, koautora 16)
Issue Date:	2013
Publication:	HAEMATOLOGICA
ISSN:	0390-6078 Haematologica Search Idenfier
Type:	Conference Paper
Collation:	vol. 98 str. 356-356
WoS-ID:	000445772400846
URI:	https://enauka.gov.rs/handle/123456789/812947
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.